|
Diabetes, Vol 46, Issue 11 1786-1791, Copyright © 1997 by American Diabetes Association
Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes
RA Anderson, N Cheng, NA Bryden, MM Polansky, N Cheng, J Chi and J Feng
Beltsville Human Nutrition Research Center, U.S. Department of Agriculture, Maryland 20705-2350, USA. anderson@307.bhnrc.usda.gov
Chromium is an essential nutrient involved in normal carbohydrate and lipid
metabolism. The chromium requirement is postulated to increase with
increased glucose intolerance and diabetes. The objective of this study was
to test the hypothesis that the elevated intake of supplemental chromium is
involved in the control of type 2 diabetes. Individuals being treated for
type 2 diabetes (180 men and women) were divided randomly into three groups
and supplemented with: 1) placebo, 2) 1.92 micromol (100 microg) Cr as
chromium picolinate two times per day, or 3) 9.6 micromol (500 microg) Cr
two times per day. Subjects continued to take their normal medications and
were instructed not to change their normal eating and living habits. HbA1c
values improved significantly after 2 months in the group receiving 19.2
pmol (1,000 microg) Cr per day and was lower in both chromium groups after
4 months (placebo, 8.5 +/- 0.2%; 3.85 micromol Cr, 7.5 +/- 0.2%; 19.2
micromol Cr, 6.6 +/- 0.1%). Fasting glucose was lower in the 19.2-micromol
group after 2 and 4 months (4-month values: placebo, 8.8 +/- 0.3 mmol/l;
19.2 micromol Cr, 7.1 +/- 0.2 mmol/l). Two-hour glucose values were also
significantly lower for the subjects consuming 19.2 micromol supplemental
Cr after both 2 and 4 months (4-month values: placebo, 12.3 +/- 0.4 mmo/l;
19.2 micromol Cr, 10.5 +/- 0.2 mmol/l). Fasting and 2-h insulin values
decreased significantly in both groups receiving supplemental chromium
after 2 and 4 months. Plasma total cholesterol also decreased after 4
months in the subjects receiving 19.2 micromol/day Cr. These data
demonstrate that supplemental chromium had significant beneficial effects
on HbA1c, glucose, insulin, and cholesterol variables in subjects with type
2 diabetes. The beneficial effects of chromium in individuals with diabetes
were observed at levels higher than the upper limit of the Estimated Safe
and Adequate Daily Dietary Intake.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Kleefstra, S. T. Houweling, and H. J.G. Bilo
Effect of Chromium Supplementation on Glucose Metabolism and Lipids: A Systematic Review of Randomized Controlled Trials: Response to Balk et al.
Diabetes Care,
September 1, 2007;
30(9):
e102 - e102.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Balk, A. H. Lichtenstein, and A. G. Pittas
Effect of Chromium Supplementation on Glucose Metabolism and Lipids: A Systematic Review of Randomized Controlled Trials: Response to Kleefstra, Houweling, and Bilo
Diabetes Care,
September 1, 2007;
30(9):
e103 - e103.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Balk, A. Tatsioni, A. H. Lichtenstein, J. Lau, and A. G. Pittas
Effect of Chromium Supplementation on Glucose Metabolism and Lipids: A systematic review of randomized controlled trials
Diabetes Care,
August 1, 2007;
30(8):
2154 - 2163.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kleefstra, S. T. Houweling, S. J.L. Bakker, S. Verhoeven, R. O.B. Gans, B. Meyboom-de Jong, and H. J.G. Bilo
Chromium Treatment Has No Effect in Patients With Type 2 Diabetes in a Western Population: A randomized, double-blind, placebo-controlled trial
Diabetes Care,
May 1, 2007;
30(5):
1092 - 1096.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Mark
Chromium Picolinate Supplementation Attenuates Body Weight Gain and Increases Insulin Sensitivity in Subjects With Type 2 Diabetes: Response to Martin et al.
Diabetes Care,
December 1, 2006;
29(12):
2764 - 2764.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Martin, D. Matthews, and W. T. Cefalu
Chromium Picolinate Supplementation Attenuates Body Weight Gain and Increases Insulin Sensitivity in Subjects With Type 2 Diabetes: Response to Mark
Diabetes Care,
December 1, 2006;
29(12):
2764 - 2765.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Rink, S. Roy, S. Khanna, T. Rink, D. Bagchi, and C. K. Sen
Transcriptome of the subcutaneous adipose tissue in response to oral supplementation of type 2 Leprdb obese diabetic mice with niacin-bound chromium
Physiol Genomics,
November 21, 2006;
27(3):
370 - 379.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A Shenkin
Micronutrients in health and disease.
Postgrad. Med. J.,
September 1, 2006;
82(971):
559 - 567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Martin, Z. Q. Wang, X. H. Zhang, D. Wachtel, J. Volaufova, D. E. Matthews, and W. T. Cefalu
Chromium Picolinate Supplementation Attenuates Body Weight Gain and Increases Insulin Sensitivity in Subjects With Type 2 Diabetes
Diabetes Care,
August 1, 2006;
29(8):
1826 - 1832.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Chen, P. Liu, G. R. Pattar, L. Tackett, P. Bhonagiri, A. B. Strawbridge, and J. S. Elmendorf
Chromium Activates Glucose Transporter 4 Trafficking and Enhances Insulin-Stimulated Glucose Transport in 3T3-L1 Adipocytes via a Cholesterol-Dependent Mechanism
Mol. Endocrinol.,
April 1, 2006;
20(4):
857 - 870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kleefstra, S. T. Houweling, F. G.A. Jansman, K. H. Groenier, R. O.B. Gans, B. Meyboom-de Jong, S. J.L. Bakker, and H. J.G. Bilo
Chromium Treatment Has No Effect in Patients With Poorly Controlled, Insulin-Treated Type 2 Diabetes in an Obese Western Population: A randomized, double-blind, placebo-controlled trial.
Diabetes Care,
March 1, 2006;
29(3):
521 - 525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wani, C. Weskamp, J. Marple, and L. Spry
Acute Tubular Necrosis Associated with Chromium Picolinate-Containing Dietary Supplement
Ann. Pharmacother.,
March 1, 2006;
40(3):
563 - 566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Aghdassi, I. E. Salit, L. Fung, L. Sreetharan, S. Walmsley, and J. P. Allard
Is Chromium an Important Element in HIV-Positive Patients with Metabolic Abnormalities? An Hypothesis Generating Pilot Study.
J. Am. Coll. Nutr.,
February 1, 2006;
25(1):
56 - 63.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Q. Wang, X. H. Zhang, J. C. Russell, M. Hulver, and W. T. Cefalu
Chromium Picolinate Enhances Skeletal Muscle Cellular Insulin Signaling In Vivo in Obese, Insulin-Resistant JCR:LA-cp Rats
J. Nutr.,
February 1, 2006;
136(2):
415 - 420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-K. Hyun, I.-Y. Kim, and S. C. Frost
Soluble Fibroin Enhances Insulin Sensitivity and Glucose Metabolism in 3T3-L1 Adipocytes
J. Nutr.,
December 1, 2004;
134(12):
3257 - 3263.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. T. Cefalu and F. B. Hu
Role of Chromium in Human Health and in Diabetes
Diabetes Care,
November 1, 2004;
27(11):
2741 - 2751.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Frauchiger, C. Wenk, and P. C. Colombani
Effects of Acute Chromium Supplementation on Postprandial Metabolism in Healthy Young Men
J. Am. Coll. Nutr.,
August 1, 2004;
23(4):
351 - 357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. V Aminot-Gilchrist and H. D. Anderson
Insulin resistance--associated cardiovascular disease: potential benefits of conjugated linoleic acid
Am. J. Clinical Nutrition,
June 1, 2004;
79(6):
1159S - 1163S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Salmi, H. C. Zisser, and L. Jovanovic
Screening for and Treatment of Polycystic Ovary Syndrome in Teenagers
Experimental Biology and Medicine,
May 1, 2004;
229(5):
369 - 377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-M. Roussel, A. Kerkeni, N. Zouari, S. Mahjoub, J.-M. Matheau, and R. A. Anderson
Antioxidant Effects of Zinc Supplementation in Tunisians with Type 2 Diabetes Mellitus
J. Am. Coll. Nutr.,
August 1, 2003;
22(4):
316 - 321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F McCarty
Chromium meta-analysis
Am. J. Clinical Nutrition,
July 1, 2003;
78(1):
191 - 192.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S Kalman
Chromium picolinate and type 2 diabetes
Am. J. Clinical Nutrition,
July 1, 2003;
78(1):
192 - 192.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D Althuis and J. T Wittes
Reply to DS Kalman, MF McCarty, and V Juturu and JR Komorowski
Am. J. Clinical Nutrition,
July 1, 2003;
78(1):
192 - 193.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J Ryan, N. S Wanko, A. R Redman, and C. B Cook
Chromium as Adjunctive Treatment for Type 2 Diabetes
Ann. Pharmacother.,
June 1, 2003;
37(6):
876 - 885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Y. Yeh, D. M. Eisenberg, T. J. Kaptchuk, and R. S. Phillips
Systematic Review of Herbs and Dietary Supplements for Glycemic Control in Diabetes
Diabetes Care,
April 1, 2003;
26(4):
1277 - 1294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D Althuis, N. E Jordan, E. A Ludington, and J. T Wittes
Glucose and insulin responses to dietary chromium supplements: a meta-analysis
Am. J. Clinical Nutrition,
July 1, 2002;
76(1):
148 - 155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. S. FACCHINI and K. L. SAYLOR
Effect of Iron Depletion on Cardiovascular Risk Factors: Studies in Carbohydrate-Intolerant Patients
Ann. N.Y. Acad. Sci.,
June 1, 2002;
967(1):
342 - 351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. T. Cefalu, Z. Q. Wang, X. H. Zhang, L. C. Baldor, and J. C. Russell
Oral Chromium Picolinate Improves Carbohydrate and Lipid Metabolism and Enhances Skeletal Muscle Glut-4 Translocation in Obese, Hyperinsulinemic (JCR-LA Corpulent) Rats
J. Nutr.,
June 1, 2002;
132(6):
1107 - 1114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Franz, J. P. Bantle, C. A. Beebe, J. D. Brunzell, J.-L. Chiasson, A. Garg, L. A. Holzmeister, B. Hoogwerf, E. Mayer-Davis, A. D. Mooradian, et al.
Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications
Diabetes Care,
January 1, 2002;
25(1):
148 - 198.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Crone, G. Gabriel, and T. N. Wise
Non-Herbal Nutritional Supplements--The Next Wave: A Comprehensive Review of Risks and Benefits for the C-L Psychiatrist
Psychosomatics,
August 1, 2001;
42(4):
285 - 299.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. S. O'Connell
Select Vitamins and Minerals in the Management of Diabetes
Diabetes Spectr,
August 1, 2001;
14(3):
133 - 148.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Volpe, H.-W. Huang, K. Larpadisorn, and I. I. Lesser
Effect of Chromium Supplementation and Exercise on Body Composition, Resting Metabolic Rate and Selected Biochemical Parameters in Moderately Obese Women Following an Exercise Program
J. Am. Coll. Nutr.,
August 1, 2001;
20(4):
293 - 306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Anderson, A.-M. Roussel, N. Zouari, S. Mahjoub, J.-M. Matheau, and A. Kerkeni
Potential Antioxidant Effects of Zinc and Chromium Supplementation in People with Type 2 Diabetes Mellitus
J. Am. Coll. Nutr.,
June 1, 2001;
20(3):
212 - 218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Bell and J. Shabert
Nutritional Modulation of Blood Parameters in Type 2 Diabetes
The Diabetes Educator,
May 1, 2001;
27(3):
368 - 375.
[PDF]
|
 |
|

|
 |

|
 |
 
J. E Gunton, G. Hams, R. Hitchman, and A. McElduff
Serum chromium does not predict glucose tolerance in late pregnancy
Am. J. Clinical Nutrition,
January 1, 2001;
73(1):
99 - 104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Vuksan, M. P Stavro, J. L Sievenpiper, V. Y. Koo, E. Wong, U. Beljan-Zdravkovic, T. Francis, A. L Jenkins, L. A Leiter, R. G Josse, et al.
American Ginseng Improves Glycemia in Individuals with Normal Glucose Tolerance: Effect of Dose and Time Escalation
J. Am. Coll. Nutr.,
June 1, 2000;
19(6):
738 - 744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Amato, A. J. Morales, and S. S. C. Yen
Effects of Chromium Picolinate Supplementation on Insulin Sensitivity, Serum Lipids, and Body Composition in Healthy, Nonobese, Older Men and Women
J. Gerontol. A Biol. Sci. Med. Sci.,
May 1, 2000;
55(5):
260M - 263.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. J. Orchard
Magnesium and Type 2 Diabetes Mellitus
Arch Intern Med,
October 11, 1999;
159(18):
2119 - 2120.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Porter, L. W. Raymond, and G. D. Anastasio
Chromium: Friend or Foe?
Arch Fam Med,
September 1, 1999;
8(5):
386 - 390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Vincent
Mechanisms of Chromium Action: Low-Molecular-Weight Chromium-Binding Substance
J. Am. Coll. Nutr.,
February 1, 1999;
18(1):
6 - 12.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. W. Campbell, L. J. O. Joseph, S. L. Davey, D. Cyr-Campbell, R. A. Anderson, and W. J. Evans
Effects of resistance training and chromium picolinate on body composition and skeletal muscle in older men
J Appl Physiol,
January 1, 1999;
86(1):
29 - 39.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Mertz
Chromium Research from a Distance: From 1959 to 1980
J. Am. Coll. Nutr.,
December 1, 1998;
17(6):
544 - 547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Anderson
Chromium, Glucose Intolerance and Diabetes
J. Am. Coll. Nutr.,
December 1, 1998;
17(6):
548 - 555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Spicer, B. J. Stoecker, T. Chen, and L. J. Spicer
Maternal and Fetal Insulin-Like Growth Factor System and Embryonic Survival During Pregnancy in Rats: Interaction between Dietary Chromium and Diabetes
J. Nutr.,
December 1, 1998;
128(12):
2341 - 2347.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1997 by the American Diabetes Association.
|
|
| |
|